Evidence map›Paper›PMID 37761093›Full record

ArticleFoods (Basel, Switzerland)2023

Metabolite Profiling for Typization of "Rucola della Piana del Sele" (PGI),

Maria Assunta Crescenzi, Antonietta Cerulli, Paola Montoro, Sonia Piacente

Open access · goldAbstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Evolution of Secondary Metabolites inFoods (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Foods (Basel, Switzerland) · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Maria Assunta CrescenziDepartment of Pharmacy, University of the Study of Salerno, Via Giovanni Paolo II, 132, I-84084 Fisciano, SA, Italy.
Antonietta CerulliDepartment of Pharmacy, University of the Study of Salerno, Via Giovanni Paolo II, 132, I-84084 Fisciano, SA, Italy.
Paola MontoroDepartment of Pharmacy, University of the Study of Salerno, Via Giovanni Paolo II, 132, I-84084 Fisciano, SA, Italy.ORCID 0000-0001-9445-6006
Sonia PiacenteDepartment of Pharmacy, University of the Study of Salerno, Via Giovanni Paolo II, 132, I-84084 Fisciano, SA, Italy.ORCID 0000-0002-4998-2311
University of Salerno · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In August 2020, the

Indexed as

metabolite profilingprotected geographical indicationtypization

Identifiers

PMID37761093
PMCPMC10529767
OpenAlexW4386600978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.